Skip to content

Correlation between DAA and PLA approaches on postoperative gait and muscle group changes in patients undergoing total hip arthroplasty: a prospective, double-blind, randomized controlled trial

Correlation between DAA and PLA approaches on postoperative gait and muscle group changes in patients undergoing total hip arthroplasty: a prospective, double-blind, randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076858
Enrollment
Unknown
Registered
2023-10-23
Start date
2023-10-23
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the hip joint

Interventions

Group A:Total hip replacement via DAA approach
Group B:Total hip replacement via PLA approach

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients who underwent initial unilateral THA at our hospital for osteoarthritis of the hip joint, femoral head necrosis (Ficat stage IIIB or IV) or hip dysplasia (Crowe type I or II); (2) American Society of Anesthesiologists (ASA) classification I to III; (3) normal quadriceps muscle strength.

Exclusion criteria

Exclusion criteria: (1) Diagnosis other than osteonecrosis of the femoral head, developmental dysplasia of the hip (rheumatoid arthritis, suppurative arthritis); (2)BMI = 35 kg/m2; (3) revision surgery; (4) severe osteoporosis; (5) high medical risk comorbidities; (6) mental disorders; (7) previous hip surgery; (8) history of hip infection; (9) Inability to communicate verbally

Design outcomes

Primary

MeasureTime frame
Gait Analysis Indicators;Muscle strength;

Secondary

MeasureTime frame
Range of hip motion;Harris Hip Score;Incidence of postoperative complications;

Countries

China

Contacts

Public ContactKang Pengde

West China Hospital, Sichuan University

724339027@qq.com+86 183 9832 7222

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026